Mosaic valve international clinical trial: Early performance results

Annals of Thoracic Surgery

Volumn 71, Issue 5, 2001, Pages S273-S277

  Fradet, Guy J ^a   Bleese, Niels ^b   Burgess, John ^c   Cartier, Paul C ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ALBERTINEN KRANKENHAUS   (Germany)

^c REGINA GENERAL HOSPITAL   (Canada)

^d Quebec Cardiology Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AORTA VALVE PROSTHESIS; BLEEDING; CONFERENCE PAPER; FEMALE; FOLLOW UP; HEART VALVE REPLACEMENT; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROSTHESIS; PRIORITY JOURNAL; SAFETY; SURVIVAL TIME; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; BIOPROSTHESIS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; REOPERATION; SURVIVAL ANALYSIS;

EID: 0035022634     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02539-5     Document Type: Article

References (10)

1. David TE, Armstrong S, Sun Z, Kuo J. The Hancock II bioprosthesis at twelve years. Ann Thorac Surg 1998;66: S95-8.
2. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-5.
3. Fradet G, Jamieson WRE, Miyagishima RT, et al. Performance by age groups in biological and mechanical cardiac valve replacement. Asian Cardiovascular Thoracic Annals 1997;5:130-6.
4. Broom N, Thomsom EJ. Influence of fixation conditions on the performance of glutaraldehyde-treated porcine aortic valves. Thorax 1979;34:166-76.
5. Gott JP, Pan-Chih, Dorsey LMA, et al. Calcification of porcine valves: a successful new method of antimineralization. Ann Thorac Surg 1992;53:207-16.
6. Lockie KJ, Fisher J, Juster NP, et al. Biomechanics of glutaraldehyde-treated porcine aortic roots and valves. J Thorac Cardiovasc Surg 1994;108:1037-42.
7. David TE, Armstong S, Sun Z. Clinical and hemodynamic assessment of the Hancock II bioprosthesis. Ann Thorac Surg 1992;54:661-7.
8. David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121:268-77.
9. David TE, Armstong S, Sun Z. The Hancock II bioprosthesis at 12 years. Ann Thorac Surg 1998;66:S95-8.
10. Schoen FJ, Levy RJ. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 1999; 47:439-65.